Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2- advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis
一线治疗帕博西尼联合来曲唑治疗ER+/HER2-晚期乳腺癌日本患者的总生存期和后续治疗模式:最终分析
期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-025-01760-0
Takahashi, Masato; Yasojima, Hiroyuki; Osako, Tomofumi; Inoue, Kenichi; Kawashima, Masahiro; Maeda, Hideki; Ito, Mitsuya; Sagara, Yasuaki; Yonemori, Kan; Hattori, Masaya; Yamamoto, Naohito; Muramatsu, Yasuaki; Matsui, Akiko; Masuda, Norikazu